Compare OGN & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | CENTA |
|---|---|---|
| Founded | 1923 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2020 | N/A |
| Metric | OGN | CENTA |
|---|---|---|
| Price | $5.85 | $32.52 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $11.75 | ★ $35.75 |
| AVG Volume (30 Days) | ★ 3.0M | 244.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.42 | $1.60 |
| Revenue Next Year | $1.67 | $2.04 |
| P/E Ratio | ★ $8.42 | $13.52 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.76 | $25.97 |
| 52 Week High | $14.94 | $37.35 |
| Indicator | OGN | CENTA |
|---|---|---|
| Relative Strength Index (RSI) | 25.56 | 49.71 |
| Support Level | N/A | $31.34 |
| Resistance Level | $7.87 | $32.95 |
| Average True Range (ATR) | 0.22 | 0.83 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 10.00 | 67.61 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.